Authors
Latest:
Practical Takeaways from FMX 2025: What Every Family Physician Should KnowFMX 2025 highlights for primary care include expert insights on vaccine confidence, chronic cough management, and vascular disease prevention.
Latest:
Prenatal Exposure to Antibiotics May Increase Risk for Long-Term Health Problems in ChildrenThe potential adverse outcomes include asthma, food allergies, cerebral palsy, and cancer, according to a recent systematic review and meta-analysis.
Latest:
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPDIn a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.
Latest:
Telemedicine vs In-person Care: In Addiction Medicine, Options are KeyCOVID-19 has dealt in-person addiction treatment a blow, but the chief medical officer of Groups Recover Together tells a telemedicine success story with a hybrid ending.
Latest:
Texting Patients? Don't Make these HIPAA MistakesTrain your staff well, says this expert in business texting solutions, and make sure to develop and use appropriate checks and balances.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
Practical Takeaways from FMX 2025: What Every Family Physician Should KnowFMX 2025 highlights for primary care include expert insights on vaccine confidence, chronic cough management, and vascular disease prevention.
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Autoimmune Disease Risk After HT: Clinical Insights From a Large Real-World StudyStudy author Daniel Jiang, MD, PhD, discusses data linking hormone therapy to increased autoimmune disease risk in postmenopausal women and clinical implications.
Latest:
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two TrialsAcross two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Latest:
Diagnosing DVT: Clinical Pearls for Challenging PresentationsA family medicine physician shares a case of massive PE presenting as syncope and explains the history questions that prevent missed DVT diagnoses in primary care.
Latest:
Vaccines, Policy, and the Erosion of Trust: A Conversation with Chuck Vega, MDVega considers the impact of recent changes in immunization policy on trust not just among patients but among clinicians as well. It all threatens good patient care, he said.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
Guidance for PCPs: Streamlining Menopause CarePanelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.
Latest:
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It WorksThe coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.
Latest:
Cannabis: An "Ins and Outs" Primer for Primary CareA concise update on legal status, FDA approvals, patient safety, and public perception.
Latest:
Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders: StudyInvestigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.
Latest:
Caroline Mitchell, MD, Describes Toll of Genitourinary Syndrome of Menopause on QoLTMS: Half of postmenopausal women suffer from GSM, yet only 25% seek treatment. Mitchell, an expert in vulvovaginal health, explains the gap and its impact on women.
Latest:
Final Pearls and Takeaways for Testing and Managing CKDExperts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
Latest:
Closing Thoughts With Patient Cases: Choosing the Right Topical Treatment for Patients With Atopic DermatitisA panelist discusses how simplifying treatment regimens, using nonsteroidal options, and fostering collaboration between primary care and dermatology can improve patient adherence and outcomes while emphasizing the importance of careful consideration when transitioning to systemic treatments or biologics due to safety concerns and patient needs.
Latest:
Closing Thoughts With Patient Cases: Choosing the Right Topical Treatment for Patients With Atopic DermatitisPanelists discuss how choosing topical treatments requires individualized therapy considering factors such as affected body areas, disease severity, patient age, formulation preferences, and insurance coverage.
Latest:
FDA Ruling on National Breast Density Notification for Mammography Reports FinalizedBeginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.
Latest:
Two Biosimilars to Denosumab Win FDA Approval as Amgen and Sandoz Go to CourtBiosimilars Wyost and Jubobonti were approved as interchangeable for Xgeva and Prolia but launch will depend on the outcome of litigation between reference product manufacturers.
Latest:
Atopic Dermatitis, Pediatric Rashes, and Contact Allergies: What’s New for PCPs from AAD 2025Highlights from AAD 2025: Experts share updates on systemic therapy for atopic dermatitis, pediatric rashes, and contact dermatitis for PCPs.
Latest:
Closing Thoughts on Treating Anaphylaxis with Epinephrine Nasal SprayA panelist discusses how education about anaphylaxis recognition, early epinephrine administration, and addressing barriers like device portability remains crucial, with intranasal epinephrine potentially solving many existing challenges in anaphylaxis management.
Latest:
Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA DecisionThe only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.
